No Data
No Data
Shanxi Zhendong Pharmaceutical (300158.SZ): has repurchased a total of 1.28% of its shares.
On May 7, at Gelonghui, Shanxi Zhendong Pharmaceutical (300158.SZ) announced that as of April 30, 2025, the company had cumulatively repurchased 12,916,700 shares through a special securities account for share buybacks via centralized bidding, accounting for 1.28% of the company's total share capital. The highest Fill Price for the repurchase was 5.03 yuan/share, the lowest Fill Price was 3.51 yuan/share, and the total amount of the repurchase was 51,025,218 yuan (excluding transaction costs).
Express News | Shanxi Zhendong Pharmaceutical invested to establish a large pharmacy company in Shanxi.
Zhendong Pharmaceutical: 2024 Annual Report
Zhendong Pharmaceutical: Report for the first quarter of 2025
Zhendong Pharmaceutical: 2024 Annual Report Summary
Shanxi Zhendong Pharmaceutical (300158.SZ) reported a Net income of 1.1572 million yuan in the first quarter, a decrease of 94.99% year-on-year.
Gelonghui April 20丨Shanxi Zhendong Pharmaceutical (300158.SZ) announced its Q1 2025 report. During the reporting period, the company's revenue was 0.755 billion yuan, a year-on-year decrease of 3.53%; the net income attributable to shareholders of the listed company was 1.1572 million yuan, a year-on-year decrease of 94.99%; the net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 0.2896 million yuan, compared to a loss of 8.5924 million yuan in the same period last year, and the EPS was 0.0012 yuan.